LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) is one of 290 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare LENZ Therapeutics to similar businesses based on the strength of its institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation. Earnings & Valuation […]